EUVIMEDEUVIMED entdecken
Crossref

Discovery of Active Compounds in Qigui Jiangzhi Formula for Metabolic Dysfunction‐Associated Steatotic Liver Disease by a Multidimensional Phenotypic Analysis

Xianghao Xu, Fanxing Zhou, Zhe Wu, Yi Zhou, Yanying Zhang, Miao Xu, Xudong Xing, Ping Li, Guangji Wang, Hua Yang iD

Phytochemical Analysis · 2026-07 · 37 (5) · 746-760

DOI: 10.1002/pca.70075 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytochemical Analysis, online erschienen am 22.04.2026. Verfasst von Xianghao Xu und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Natural Medicines, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, China. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Fatty Liver. Die Arbeit nennt 48 Literaturangaben. Gefördert von: Chief Scientist Research Project of Hubei Shizhen Laboratory, Jiangsu Provincial Integrated Innovation Center of Traditional Chinese Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The incidence of metabolic dysfunction‐associated steatotic liver disease (MASLD) is rising steadily. Clinically, the Qigui Jiangzhi Formula (QGJZF) has been proven to be capable of effectively improving the conditions of patients with hyperlipidemia and those with metabolic‐associated fatty liver disease by regulating the pathways of glucose and lipid metabolism.

Purpose

This study aims to establish a strategy based on multidimensional phenotypic characteristics to screen for active compounds in QGJZF that can improve abnormal glucose and lipid metabolism.

Methods

A multidimensional phenotypic method for liver cells based on high‐content imaging has been developed. This method can correlate biological processes with morphological data, such as glucose metabolism, lipid metabolism, energy metabolism, and oxidative stress in MASLD. The chemical‐phenotypic correlation analysis has identified the active compounds in QGJZF by activity score and cluster score. These scores were obtained by combining the mass spectrometry ion data of each fraction of QGJZF with the multidimensional phenotypic data. The data of active compounds were combined with network pharmacology for analysis, thereby elucidating the mechanism of QGJZF in improving MASLD.

Results

Among the 199 cell phenotypic parameters obtained by multidimensional phenotypic method, 99, 51, 131, and 76 were respectively associated with glucose metabolism disorders, lipid metabolism disorders, energy metabolism disorders, and oxidative stress in MASLD. Subsequently, 23 active compounds were identified in QGJZF that improve glucose metabolism homeostasis, ameliorate lipid metabolism disorders, restore energy metabolism balance, and alleviate oxidative damage. The combined analysis of active compounds and network pharmacology results indicates that their mechanism of action may involve the AGE‐RAGE, MASLD‐related, AMPK, and HIF‐1 signaling pathways.

Conclusions

This study overcame the limitations of single‐indicator screening methods for MASLD by proposing a multidimensional phenotypic method. Using this method, the active compounds in QGJZF and the key pathways through which they improve MASLD were identified.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drugs, Chinese HerbalFatty LiverPhenotypeHumansLipid MetabolismOxidative StressGlucoseNetwork PharmacologyEnergy Metabolism

Stichwörter der Autor:innen

Qigui Jiangzhi formulahigh‐content screeningmetabolic dysfunction‐associated steatotic liver diseasemultidimensional phenotypic method

Substanzen

Drugs, Chinese HerbalGlucose

Autor:innen und Institutionen

  • State Key Laboratory of Natural Medicines, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, China.
  • Hubei Shizhen Laboratory, Wuhan, China.

ORCID-Profile: Hua Yang

Förderung

  • Chief Scientist Research Project of Hubei Shizhen Laboratory
  • Jiangsu Provincial Integrated Innovation Center of Traditional Chinese Medicine

Zitieren

APA

Xu, X., Zhou, F., Wu, Z., Zhou, Y., Zhang, Y., Xu, M., Xing, X., Li, P., Wang, G., & Yang, H. (2026). Discovery of Active Compounds in Qigui Jiangzhi Formula for Metabolic Dysfunction‐Associated Steatotic Liver Disease by a Multidimensional Phenotypic Analysis. Phytochemical Analysis, 37(5), 746-760. https://doi.org/10.1002/pca.70075

Vancouver

Xu X, Zhou F, Wu Z, Zhou Y, Zhang Y, Xu M, et al. Discovery of Active Compounds in Qigui Jiangzhi Formula for Metabolic Dysfunction‐Associated Steatotic Liver Disease by a Multidimensional Phenotypic Analysis. Phytochemical Analysis. 2026;37(5):746-760. doi:10.1002/pca.70075

BibTeX
@article{Xu2026,
  author = {Xu, Xianghao and Zhou, Fanxing and Wu, Zhe and Zhou, Yi and Zhang, Yanying and Xu, Miao and Xing, Xudong and Li, Ping and Wang, Guangji and Yang, Hua},
  title = {Discovery of Active Compounds in Qigui Jiangzhi Formula for Metabolic Dysfunction‐Associated Steatotic Liver Disease by a Multidimensional Phenotypic Analysis},
  journal = {Phytochemical Analysis},
  year = {2026},
  volume = {37},
  number = {5},
  pages = {746--760},
  doi = {10.1002/pca.70075}
}
Kostenlos starten →